Reddel S W, Barnett M H, Yan W X, Halmagyi G M, Pollard J D
The Royal Prince Alfred Hospital, Sydney, Australia.
Neurology. 2000 Feb 22;54(4):1000-2. doi: 10.1212/wnl.54.4.1000.
Anti-GQ1b antibodies are typically found in patients with the Miller Fisher syndrome, all of whom will have, by definition, acute ophthalmoplegia. The authors describe three patients with chronic ophthalmoplegia in the presence of persistently high titers of immunoglobulin G anti-GQ1b antibody detected in an ELISA, one of whom improved with immunotherapy. Anti-GQ1b antibodies may be associated with some cases of chronic ophthalmoplegia of unknown cause.
抗GQ1b抗体通常在米勒费雪综合征患者中发现,根据定义,所有这些患者都会有急性眼肌麻痹。作者描述了3例慢性眼肌麻痹患者,其在酶联免疫吸附测定(ELISA)中检测到免疫球蛋白G抗GQ1b抗体滴度持续升高,其中1例患者经免疫治疗后病情改善。抗GQ1b抗体可能与某些病因不明的慢性眼肌麻痹病例有关。